Dow Up 0.08% Nasdaq Down 0.30%

Theravance Inc. (THRX)

-NasdaqGS
18.72 Up 0.09(0.48%) 4:00PM EDT
|After Hours : 18.72 0.00 (0.00%) 4:40PM EDT
Prev Close:18.63
Open:18.67
Bid:18.00 x 1000
Ask:20.00 x 300
1y Target Est:29.86
Beta:0.72
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:18.51 - 18.98
52wk Range:18.02 - 34.53
Volume:2,333,243
Avg Vol (3m):982,248
Market Cap:2.15B
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXUp 0.48%2.15B
AZNUp 0.76%94.37B
CBSTDown 0.82%5.04B
PFEDown 0.59%192.76B

Key Statistics

Forward P/E (1 yr):234.00
P/S (ttm):944.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.21
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback